Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.

Drug Des Devel Ther · 2016 · PMC5055118 · PMID 27757013

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

24 While higher pain-free rates at 2 hours were achieved with frovatriptan versus zolmitriptan and almotriptan, these did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.